242 related articles for article (PubMed ID: 3170507)
1. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
2. Production of monoclonal antibodies specific for ganglioside GD3.
Watarai S; Onuma M; Yasuda T
J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
[TBL] [Abstract][Full Text] [Related]
3. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.
Tai T; Kawashima I; Furukawa K; Lloyd KO
Arch Biochem Biophys; 1988 Jan; 260(1):51-5. PubMed ID: 2449128
[TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
[TBL] [Abstract][Full Text] [Related]
7. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides.
Ozawa H; Kotani M; Kawashima I; Tai T
Biochim Biophys Acta; 1992 Jan; 1123(2):184-90. PubMed ID: 1371229
[TBL] [Abstract][Full Text] [Related]
8. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
Ozawa H; Kawashima I; Tai T
Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
[TBL] [Abstract][Full Text] [Related]
9. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to ganglio-series gangliosides in different strains of inbred mice.
Kawashima I; Nakamura O; Tai T
Mol Immunol; 1992 May; 29(5):625-32. PubMed ID: 1584231
[TBL] [Abstract][Full Text] [Related]
11. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
12. GD3 expression by cultured human tumor cells of neuroectodermal origin.
He X; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Acta Neuropathol; 1989; 79(3):317-25. PubMed ID: 2609939
[TBL] [Abstract][Full Text] [Related]
13. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
Kotani M; Ozawa H; Kawashima I; Ando S; Tai T
Biochim Biophys Acta; 1992 Jul; 1117(1):97-103. PubMed ID: 1627599
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.
Brindel I; Preud'homme JL; Vallat JM; Vincent D; Vasquez JL; Jauberteau MO
Neurosci Lett; 1994 Nov; 181(1-2):103-6. PubMed ID: 7534889
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
Fukuta S; Werkmeister JA; Burns GF; Ginsburg V; Magnani JL
J Biol Chem; 1987 Apr; 262(10):4800-3. PubMed ID: 2435716
[TBL] [Abstract][Full Text] [Related]
16. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
Brodin T; Hellström I; Hellström KE; Karlsson KA; Sjögren HO; Strömberg N; Thurin J
Biochim Biophys Acta; 1985 Dec; 837(3):349-53. PubMed ID: 3840699
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of gangliosides from Theileria sergenti.
Watarai S; Sugimoto C; Hosotani-Kaihara K; Kobayashi K; Onuma M; Lee JT; Kushi Y; Handa S; Yasuda T
J Vet Med Sci; 1996 Nov; 58(11):1099-105. PubMed ID: 8959658
[TBL] [Abstract][Full Text] [Related]
18. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
[TBL] [Abstract][Full Text] [Related]
19. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
Hirabayashi Y; Hamaoka A; Matsumoto M; Matsubara T; Tagawa M; Wakabayashi S; Taniguchi M
J Biol Chem; 1985 Oct; 260(24):13328-33. PubMed ID: 2414279
[TBL] [Abstract][Full Text] [Related]
20. Binding of monoclonal antibody A2B5 to gangliosides.
Kundu SK; Pleatman MA; Redwine WA; Boyd AE; Marcus DM
Biochem Biophys Res Commun; 1983 Nov; 116(3):836-42. PubMed ID: 6651849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
